Protox Therapeutics Inc T.PRX

NR - When?

[cabbieJBJ]

Invite the board to weigh in on when and what.

My take at this point is the Protox has had the data long enough to do the analyses.  If the results were dissapointing there woudl have been a NR, imo.  Therfore, I this suggests that they are shopping the results to interested business partners and possibly venture capital folks (an option to proceed with phase 3 without a partner if deals are not compelling).

The waiting is killing me. 

HELP!

[bioboy10]

I agree, they must have a idea of what they have. I also think that with the stock still acting fairly strong is a good indication that the news is positive, or not enough to tank the stock.phase 3 would require a lot of money and time, any idea of how much it would cost ?. Partnering would be the way to go.I am willing to wait for next year, as after this week there will be little interest in the

[cabbieJBJ]

I seem to recall that Phase 2b cost was in the $5 million range - but I'm really guessing.  Phase 3 would run 3-4X that amount, assuming that the design will mirror 2b - which is a reasonable assumption if efficacy holds and side effects/adverse reaction remain a non issue.  They may only need to extend 2b to a larger population base to confirm statistical significance. 

[major3]

There will be no news until the first week of January (good or bad). You can bet they have had the raw data for the past few weeks and yes they could be in the process of negotiating deals if the data is positive. I see no reason why the results in this study would be any different from what they got on Phase 2a. Any Placebo effect would be short term as those participants with the placebo would